John W. Walsh Alpha-1 Home Infusion Act of 2022
USA117th CongressHR-7346| House
| Updated: 4/1/2022
Maria Elvira Salazar
Republican Representative
Florida
Cosponsors (15)
Brian Higgins (Democratic)John A. Yarmuth (Democratic)Mondaire Jones (Democratic)Jimmy Panetta (Democratic)Paul Tonko (Democratic)John B. Larson (Democratic)Chris Jacobs (Republican)William R. Keating (Democratic)Deborah K. Ross (Democratic)Mike Thompson (Democratic)Bill Posey (Republican)Burgess Owens (Republican)Debbie Wasserman Schultz (Democratic)Gerald E. Connolly (Democratic)Chellie Pingree (Democratic)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
John W. Walsh Alpha-1 Home Infusion Act of 2022 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Health
John W. Walsh Alpha-1 Home Infusion Act of 2022
USA117th CongressHR-7346| House
| Updated: 4/1/2022
John W. Walsh Alpha-1 Home Infusion Act of 2022 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Maria Elvira Salazar
Republican Representative
Florida
Cosponsors (15)
Brian Higgins (Democratic)John A. Yarmuth (Democratic)Mondaire Jones (Democratic)Jimmy Panetta (Democratic)Paul Tonko (Democratic)John B. Larson (Democratic)Chris Jacobs (Republican)William R. Keating (Democratic)Deborah K. Ross (Democratic)Mike Thompson (Democratic)Bill Posey (Republican)Burgess Owens (Republican)Debbie Wasserman Schultz (Democratic)Gerald E. Connolly (Democratic)Chellie Pingree (Democratic)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted